| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/13/2009 | US20090202564 Methods of isolating stem cells |
| 08/13/2009 | US20090202563 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 08/13/2009 | US20090202558 TNFalpha-NEUTRALIZING ANTIBODIES |
| 08/13/2009 | US20090202556 Anti-claudin-4 antibody |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202545 Melanoma biomarker and methods of uses |
| 08/13/2009 | US20090202544 Methods of Treating Diseases by Targeting Silt3 |
| 08/13/2009 | US20090202543 Gene and polypeptide relating to breast cancer |
| 08/13/2009 | US20090202531 Uses of anti-cd40 antibodies |
| 08/13/2009 | US20090202530 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/13/2009 | US20090202529 Use of egfr inhibitors to prevent or treat obesity |
| 08/13/2009 | US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides |
| 08/13/2009 | US20090202520 Treatment and diagnostic methods for fibrosis related disorders |
| 08/13/2009 | US20090202519 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
| 08/13/2009 | US20090202517 Agents for improving inflammatory bowel disease |
| 08/13/2009 | US20090202516 Inhibition and treatment of gastrointestinal biofilms |
| 08/13/2009 | US20090202515 Agents for suppressing neural fibrotic degeneration |
| 08/13/2009 | US20090202514 Agents for improving chronic obstructive pulmonary diseases |
| 08/13/2009 | US20090202513 Ribonuclease and thiazolidinedione compounds and their use in methods to treat cancer |
| 08/13/2009 | US20090202512 Proteins for use in human and animal staphylococcus infections |
| 08/13/2009 | US20090202510 Altered sumoylation of lamin a protein associated with dilated cardiomyopathy |
| 08/13/2009 | US20090202508 Negative regulation of hypoxia inducible factor 1 by os-9 |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202502 Hepatic stellate cell specific promoter and uses thereof |
| 08/13/2009 | US20090202500 Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues |
| 08/13/2009 | US20090202499 Human Telomerase Reverse Transcriptase Peptides |
| 08/13/2009 | US20090202498 Direct differentiation of cardiomyocytes from human embryonic stem cells |
| 08/13/2009 | US20090202474 Expression of orphan gpr64 in inflammatory diseases |
| 08/13/2009 | US20090202471 Molecules with effects on cellular development and function |
| 08/13/2009 | US20090202469 Detection of inflammatory disease and composition for preventing or treatment of inflammatory disease |
| 08/13/2009 | US20090202440 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 08/13/2009 | US20090202431 Stem-like cells in bone sarcomas |
| 08/13/2009 | US20090202429 Methods for testing anti-thrombotic agents |
| 08/13/2009 | US20090202108 Assaying and imaging system identifying traits of biological specimens |
| 08/13/2009 | DE202007018829U1 Produkt mit Magnetbeads, die eine funktionalisierte Oberfläche aufweisen Product with magnetic beads that have a functionalized surface |
| 08/13/2009 | DE102008008558A1 Verfahren zur Gewinnung olfaktorischer Epithelzellen aus nicht-menschlichen embryonalen Stammzellen Process for the recovery of olfactory epithelial cells from non-human embryonic stem cells |
| 08/13/2009 | DE102008008313A1 Amplifikation von bisulfitierten Nukleinsäuren Amplification of nucleic acids bisulfited |
| 08/13/2009 | CA2715127A1 Siva3, its preparation and use |
| 08/13/2009 | CA2714630A1 Cis reactive oxygen quenchers integrated into linkers |
| 08/13/2009 | CA2714400A1 Brassica ogura restorer line r1931 with shortened raphanus fragment (srf) |
| 08/13/2009 | CA2714393A1 Prediction and diagnosis of canine degenerative myelopathy |
| 08/13/2009 | CA2714378A1 Treatment of chronic pain with zinc finger proteins |
| 08/13/2009 | CA2714121A1 Selection of rna-aptamers as anti-malaria agents |
| 08/13/2009 | CA2714095A1 Cell culture method and screening method |
| 08/13/2009 | CA2713966A1 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 08/13/2009 | CA2713909A1 Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions |
| 08/13/2009 | CA2713871A1 Sequences associated with tdp-43 proteinopathies and methods of using the same |
| 08/13/2009 | CA2713850A1 Biomarkers for head-and-neck cancers and precancers |
| 08/13/2009 | CA2713754A1 Synthetic surfaces for culturing cells in chemically defined media |
| 08/13/2009 | CA2713276A1 Selectivity profiling of pi3k interacting molecules against multiple targets |
| 08/13/2009 | CA2713156A1 Methods of diagnosing and treating parp-mediated diseases |
| 08/13/2009 | CA2712991A1 Regulation of fibroblastic growth factor-2 (fgf-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields |
| 08/13/2009 | CA2712426A1 Paired end sequencing |
| 08/13/2009 | CA2712080A1 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 08/13/2009 | CA2711265A1 Assessment of oral cavity bioflora |
| 08/12/2009 | EP2088435A1 Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate |
| 08/12/2009 | EP2088432A1 Methods for identification of an antibody or a target |
| 08/12/2009 | EP2088210A2 Improved bisulfite conversion of DNA |
| 08/12/2009 | EP2088209A1 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 08/12/2009 | EP2088208A1 Method for detecting carcinoma and agent for suppressing carcinoma |
| 08/12/2009 | EP2088207A1 Biomarkers and methods for identification of agents useful in the treatment of affective disorders |
| 08/12/2009 | EP2088206A2 Induction of the mitochondrial permeability transition |
| 08/12/2009 | EP2088205A1 PSMB10: A diagnosis marker and therapeutic target of chronic rejection. |
| 08/12/2009 | EP2088204A1 Method and kit for diagnosing or controlling the treatment of ovarian cancer |
| 08/12/2009 | EP2088203A1 Method for screening allergic disease-related molecule and cell line to be used in the method |
| 08/12/2009 | EP2088194A1 Method for selecting hop line and breeding marker and primer set used for selecting hop line |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2087152A1 Endometrial biomarkers |
| 08/12/2009 | EP2087140A2 Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| 08/12/2009 | EP2087139A2 Gene expression profiling based identification of genomic signatures of high-risk multiple myeloma and uses thereof |
| 08/12/2009 | EP2087138A1 Microarray for the detection of an angiostatic tumor stage of colorectal carcinoma |
| 08/12/2009 | EP2087137A1 A molecule for providing a standard for the quantitative analysis of the methylation status of a nucleic acid |
| 08/12/2009 | EP2087136A2 Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication |
| 08/12/2009 | EP2087135A2 Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
| 08/12/2009 | EP2087134A2 Method for diagnosis of and following a bacterial vaginosis by molecular quantification |
| 08/12/2009 | EP2087133A2 Improved hybridisation of nucleic acids |
| 08/12/2009 | EP2087132A1 Luciferase signal enhancng compositions |
| 08/12/2009 | EP2087131A1 Method for measuring the concentration of transient proteolytic activity in composite biological media containing cells |
| 08/12/2009 | EP2087130A2 Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms |
| 08/12/2009 | EP2087129A2 Method for identifying modulators of the nrf2-keap1-are pathway |
| 08/12/2009 | EP2087100A1 Labeling of human epidermal stem cells |
| 08/12/2009 | EP2087095A1 In vitro cultivation of helicobacter species |
| 08/12/2009 | EP2087043A1 New ds dna binding fluorescent dyes |
| 08/12/2009 | EP1969146A4 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities |
| 08/12/2009 | EP1937834A4 Methods for the amplification, quantitation and identification of nucleic acids |
| 08/12/2009 | EP1913155A4 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 08/12/2009 | EP1896602A4 Improved primer-based amplification methods |
| 08/12/2009 | EP1888607A4 Polymer compositions and uses thereof |
| 08/12/2009 | EP1871892A4 Device for rapid detection and identification of single microoganisms without preliminary growth |
| 08/12/2009 | EP1856275B1 A method and kit for determination of thymidine kinase activity and use thereof |
| 08/12/2009 | EP1838873A4 Method and apparatus for chromosome profiling |
| 08/12/2009 | EP1828403A4 Protein subcellular localization assays using split fluorescent proteins |
| 08/12/2009 | EP1799857A4 Detection of cancer cells in body fluids |
| 08/12/2009 | EP1784503A4 Urine markers for detection of bladder cancer |
| 08/12/2009 | EP1776449A4 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 08/12/2009 | EP1687323A4 Methods and compositions for seamless cloning of nucleic acid molecules |
| 08/12/2009 | EP1634074B1 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 08/12/2009 | EP1589814B1 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 08/12/2009 | EP1546376B9 Oligonucleotides for genotyping thymidylate synthase gene |